lol,,,I think the overall market going down today causing some shorts to cover and collect profit here.
Interesting question and I thought the same too...But in reality, I'm sure Perceptive is having some serious conversations with management.
hey mort glad to see you back..that was painful eh? I agree it takes about a week to settle after CRL and binary event. I do believe we have 2 more binary events ahead of us. If we take the CRL at face value and no clinical trials are needed, then we should be back around 8 a share. That will be disclosed after the meeting with the FDA to discuss the CRL contents. At that time, we will learn if it is a class 1 re-submission and a better idea if the human factors testing and benchmarks will suffice. THE OUTCOME OF THAT MEETING IS SORT OF BINARY to me. Otherwise, we are looking at longer runway to approval, which is another binary even in itself.
I agree, however, this is the ONE concern holding back the stock. If more clinical trials are needed, then the will be delayed longer. If not, then we could see approval Q1 2015. The FDA meeting is like another binary event!
Ask your biotech analyst a question for me, and it is a CRAZY one but it stays in my mind. Is there a potential conspiracy theory with Big Pharma applying pressure on the FDA to keep this from hitting the market? Sounds crazy, yes? But just look in the news ...nuff said
One of the reasons I was long was the impressive BOD
yes I talked about yesterday on twitter, glass half full approach is that they have more time to prepare for launch
human factors testing with fda will be established